Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 17, 2010
Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium
Devyani Deshpande, Shashikant Srivastava, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling
Shashikant Srivastava, Carleton Sherman, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
May 20, 2009
Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs
Tawanda Gumbo, Chandima S W Siyambalapitiyage Dona, Claudia Meek, et al.
The Journal of Infectious Diseases
|
October 25, 2011
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability
Shashikant Srivastava, Jotam G Pasipanodya, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
The Journal of Infectious Diseases
|
March 10, 2010
Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol
Shashikant Srivastava, Sandirai Musuka, Carleton Sherman, et al.
International Journal of Pharmaceutical Compounding
|
December 3, 2015
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals
Claudia Meek, Andrew Rothardt, Jason Evans, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
November 24, 2016
Raman Spectroscopy: A Sensitive and Specific Technique for Determining the Accuracy of Compounded Pharmaceutical Formulations
Claudia Meek, Jihye Hoe, Jason Evans, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection
Devyani Deshpande, Shashikant Srivastava, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2011
Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Antimicrobial Agents and Chemotherapy
|
March 17, 2010
Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium
Devyani Deshpande, Shashikant Srivastava, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling
Shashikant Srivastava, Carleton Sherman, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
May 20, 2009
Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs
Tawanda Gumbo, Chandima S W Siyambalapitiyage Dona, Claudia Meek, et al.
The Journal of Infectious Diseases
|
October 25, 2011
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability
Shashikant Srivastava, Jotam G Pasipanodya, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
The Journal of Infectious Diseases
|
March 10, 2010
Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol
Shashikant Srivastava, Sandirai Musuka, Carleton Sherman, et al.
International Journal of Pharmaceutical Compounding
|
December 3, 2015
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals
Claudia Meek, Andrew Rothardt, Jason Evans, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
November 24, 2016
Raman Spectroscopy: A Sensitive and Specific Technique for Determining the Accuracy of Compounded Pharmaceutical Formulations
Claudia Meek, Jihye Hoe, Jason Evans, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection
Devyani Deshpande, Shashikant Srivastava, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2011
Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
Page
of 2